Chengdu
Sichuan Province
Clover is a China-based biotechnology company that researches and develops transformative biological therapies to treat oncology and autoimmune diseases for patients.. Read more
Clover is a China-based biotechnology company that researches and develops transformative biological therapies to treat oncology and autoimmune diseases for patients.. Read more
News
Apr 03, 2025
Benzinga
Clover Biopharmaceuticals: Dispute Over Covid Vaccines Casts Doubt On Clover Bio Recovery
Mar 25, 2025
Pharmabiz
Clover Biopharmaceuticals: Clover Biopharma receives IND clearance from US FDA and begins revaccination clinical study for RSV vaccine candidate SCB1019
Oct 30, 2024
Pharmabiz
Clover Biopharmaceuticals: Clover announces positive clinical data for RSV vaccine candidate SCB1019 compared headtohead versus GSK's Arexvy
Jun 20, 2024
Pharmabiz
Clover Biopharmaceuticals: Clover reports positive preliminary phase?results for bivalent RSV vaccine candidate SCB1019 in older adults
Apr 08, 2024
MarketScreener
Clover Biopharmaceuticals: Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
Dec 30, 2023
Pharmabiz
Clover Biopharmaceuticals: Clover reports positive results from phase I trial of SCB219M to treat cancer patients with chemotherapyinduced thrombocytopenia
Dec 13, 2023
centralcharts
Press Release: Clover Biopharmaceuticals : Clover Initiates Phase Clinical Trial for RSV Vaccine Candidate
Nov 08, 2023
Pharmabiz
Clover Biopharmaceuticals: Clover Biopharma completes BLA submission for seasonal influenza vaccine in Brazil
Sep 18, 2023
ChinaBio Today
Clover Biopharmaceuticals: Clover Biopharma Starts China Distribution of Quadrivalent Seasonal Flu Vaccine
Jul 11, 2023
Life Care News
Clover Biopharmaceuticals: Clover Provides Updates on Business and R&D Pipeline
